Peripheral leukocyte response to oncological radiotherapy: Expression of Heat Shock Proteins

International Journal of Radiation Biology

Volumn 82, Issue 3, 2006, Pages 171-179

  Guisasola, M C ^a   Calvo, F ^a   Marcos, P ^a   Simon I ^a   Villanueva, F J ^a   Andres E ^a   Suarez A ^a   Garcia Barreno P ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cell biology; Flow cytometry; Gene expression; Immunology; Leukocytes; Radiotherapy; Stress proteins

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70.1; HEAT SHOCK PROTEIN 70.3; HEAT SHOCK PROTEIN ANTIBODY; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BIOSENSOR; CANCER RADIOTHERAPY; CELL LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENDOCRINE TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; FLOW CYTOMETRY; GENE; GENE CONTROL; GENE EXPRESSION; HSP GENE; HSP27 GENE; HUMAN; HUMAN CELL; MALE; MORBIDITY; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TISSUE INJURY;

AGED; AUTOANTIBODIES; FEMALE; FLOW CYTOMETRY; HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPHILS; RNA, MESSENGER;

EID: 33646482097     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000600643516     Document Type: Article

References (50)

1. Bachelet M, Mariéthoz E, Banzet N, Souil E, Pinot F, Polla CZ, Durand P, Bouchaert I, Polla BS. 1998. Flow cytometry is a rapid and reliable method for evaluating heat shock protein 70 in human monocytes. Cell Stress & Chaperones 3:168-176.
2. Bentzeb SM, Overgaard J. 1997. Clinical manifestations of normal-tissue damage. In: Steel GG, editor. Basic clinical radiobiology. 2nd ed. London: Arnold. pp 87-97.
3. Clark PR, Ménoret A. 2001. The inducible Hsp70 as a marker of tumor immunogenicity. Cell Stress & Chaperones 6:121-125.
4. Currie RW, Wu T, Tanguay RM. 2004. Stress under the dam: Meeting report of the 4th International Workshop on the Molecular Biology of Stress Responses. Cell Stress & Chaperones 9:221-228.
5. Chomezynski P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532-537.
6. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, Foster CS. 2000. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Reserach 60:7099-7105.
7. Cox JD, Stetz J, Pajak TF. 1995. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology Biology Physics 31:1341-1346.
8. Fehrenbach E, Niess AM, Schlotz E, Passek F, Dickhuth HH, Northoff H. 2000. Transcriptional and translational regulation of heat shock proteins in leukocytes of endurance runners. Journal of Applied Physiology 89:704-710.
9. Gause WC, Adamovicz J. 1995. Use of PCR to quantitate relative differences in gene expresion. In: Dieffenbach CW, Dvekseler GS, editors. PCR Primer: A laboratory manual. New York: Cold Spring Harbor Laboratory Press. pp 293-311.
10. Geisler JP, Geisler HE, Tammela J, Miller GA, Wiemann MC, Zhou Z. 1999. A study of heat shock protein 27 in endometrial carcinoma. Ginecologic Oncology 72:347-350.
11. Gibbons NB, Watson RW, Coffey RN, Brady HP, Fitzpatrick JM. 2000. Heat shock proteins inhibit induction of prostate cancer cell apoptosis. Prostate 45:58-65.
12. Goldbaum O, Richter-Landsberg C. 2001. Stress proteins in oligodendrocytes: Differential effects of heat shock and oxidative stress. Journal of Neurochemistry 78:1233-1242.
13. Gurbuxani S, Bruey JM, Frommentin A, Larmonier N, Parcellier A, Jäättela M, Martin F, Solary E, Garrido C. 2001. Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene 20:7478-7485.
14. Haikonen J, Rantanen V, Pekkola K, Kulmala J, Grenman R. 2003. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual? International Journal of Cancer 103:784-788.
15. Halford W. 1999. The essential prerequisites for quantitative RT-PCR. Nature Biotechnology 17:835.
16. Hashiguchi N, Ogura H, Tanaka H, Koh T, Aoki M, Shiozaki T, Matsuoka T, Shimazu T. Sugimoto H. 2001. Enhanced expression of heat shock proteins in leukocytes from trauma patients. The Journal of TRAUMA Injury, Infection, and Critical Care 50:102-107.
17. Hengen PN. 1995. Quantitative PCR: An accurate measure of mRNA? Trends in Biochemical Sciences 20:476-477.
18. Hoos A, Levey DL. 2003. Vaccination with heat shock protein-peptide complexes: From basic science to clinical applications. Expert Review of Vaccines 2:369-379.
19. Hunt CR, Dix DJ, Sharma GG, Pandita RK, Gupta A, Funk M, Pandita TK. 2004. Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice. Molecular and Cellular Biology 24:899-911.
20. Ishihara K, Horiguchi K, Yamagishi N, Hatayama T. 2003. Identification of sodium salicylate as an hsp inducer using a simple screening system for stress response modulators in mammalian cells. European Journal of Biochemistry 270: 3461-3468.
21. Jäätela M. 1999. Heat shock proteins as cellular lifeguards. Annals of Medicine 31:261-271.
22. Kang CM, Park KP, Song JE, Jeoung DI, Cho CK, Kim TH, Bae S, Lee SJ, Lee YS. 2003. Possible biomarkers for ionizing radiation exposure in human peripheral blood lymphocytes. Radiation Research 159:312-319.
23. Kaseem H Sh, Sangar V, Cowan R, Clarke N, Margirson GP. 2002. A potential role of heat shock proteins and nicotinamide N-Methyl trasferase in predicting response to radiation in bladder cancer. International Journal of Cancer 101:454-460.
24. Kocsis J, Veres A, Vatay A, Duba J, Karadi I, Fust G, Prohaszka Z. 2002. Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease. Immunological Investigations 31:219-231.
25. Korneeva I, Bongiovanni AM, Girotra M, Caputo TA, Witkin SS. 2000. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers. American Journal of Obstetrics and Gynecology 18:18-21.
26. Kvinnsland Y, Muren LP, Dahl O. 2004. A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of equivalent uniform doses and the volume parameter, Physics in Medicine and Biology 49: 3341-3352.
27. Legal JD, De Crevoisier R, Lartigau E, Morsli K, Dossou J, Chavaudra N, Sanfilippo N, Bourhis J, Eschwege F, Parmentier C. 2002. Chromosomal aberrations induced by chemotherapy and radiotherapy in lymphocytes from patients with breast carcinoma. International Journal of Radiation Oncology Biology Physics 52:1186-1195.
28. LENT-SOMA Tables. 1995. Tables of contents. Radiotherapy and Oncology 35:17-60.
29. Li Z, Menoret A, Srivastava P. 2002. Roles of heat-shock proteins in antigen presentation and cross-presentation. Current Opinion in Immunology 14:45-51.
30. Lorimore SA, Coates PJ, Scobie GE, Milne G, Wright EG. 2001. Inflammatory-type responses after exposure to ionizing radiation in vivo: A mechanism for radiation-induced bystander effects? Oncogene 20:7085-7095.
31. Mcilrath J, Lorimore A, Coates PJ, Wright EG. 2003. Radiation-induced instability in immortalized haemopoietic stem cell. International Journal of Radiation Biology 79:27-34.
32. Matzinger P. 1994. Tolerance, danger and the extended family. Annual Review of Immunology 12:991-1045.
33. Mazzaferro V, Coppa J, Carrabba MG, Rivoltini L, Schiavo M, Regalia E, Mariani L, Camerini T, Marchiano A, Andreola S, Camerini R, Corsi M, Lewis JJ, Srivastava PK, Parmiani G. 2003. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clinical Cancer Research 9:3235-3245.
34. Maridonneau-Parini I, Malawista SE, Stubbe H, Russo-Marie F, Polla BS. 1993. Heat shock in human neutrophils: Superoxide generation is inhibited by a mechanism distinct from heat-denaturation of NADPH oxidase and is protected by heat shock proteins in thermotolerant cells. Journal of Cellular Physiology 156:204-211.
35. Melkonyan HS, Usakova TE, Umansky SR. 1995. Hsp70 gene expression in mouse lung cells upon chronic gamma-irradiation. International Journal of Radiation Biology 68: 277-280.
36. Morimoto RI, Santoro MG. 1998. Stress inducible responses and heat shock proteins: New pharmacologic targets for cytoprotection. Nature Biotechnology 16:833-838.
37. Morimoto RI. 1998. Regulation of the heat shock transcriptional response: Cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Development 12:3788-3796.
38. Ogura H, Hashiguchi N, Tanaka H, Koh T, Noborio M, Nakamor Y, Nishino M, Kuwagata Y, Shimazu T, Sugimoto H. 2002. Long-term enhanced expression of heat shock proteins and decelerated apoptosis in polymorphonuclear leukocytes from major burn patients. Journal of Burn Care & Rehabilitation 23:103-109.
39. Peng J, Jones GL, Watson K. 2000. Stress proteins as biomarkers of oxidative stress: Effects of antioxidant supplements. Free Radical Biology & Medicine 28:1598-1606.
40. Pockley AG. 2002. Heat Shock Proteins, inflammation, and cardiovascular disease. Circulation 105:1012-1017.
41. Rieger TR, Morimoto RI, Hatzimanikatis V. 2004. Mathematical modeling of the eukaryotic heat shock response: Dynamics of the hsp70 promoter. Biophysics Journal 88:1646-1658.
42. Sanchez-Nieto B, Nahum AE, Dearnaley DP. 2001. Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data. International Journal of Radiation Oncology Biology Physics 49:487-499.
43. Sindelar WF, Kinsella TJ. 2003. Normal tissue tolerance to intraoperative radiotherapy. Surgery Oncology of Clinics of North America 2:925-942.
44. Simón I. 2001. Heat Shock Proteins in human polimorphonuclear leukocytes. Pharmacological targets. Thesis, Pharmacy Faculty, Complutense, University of Madrid. 134 p.
45. Wang XY, Manjili MH, Park J, Chen X, Elizabeth Repasky E, Subjeck JR. 2004. Development of cancer vaccines using autologous and recombinant high molecular weight stress proteins. Methods 32:13-20.
46. Welch WJ. 2001. Heat Shock proteins as biomarkers for stroke and trauma. American Journal of Medicine 111:669-670.
47. Witkin SS. 2001. Heat shock protein expression and immunity: Relevance to gynecologic oncology. European Journal of Gynaecological Oncology 4:249-256.
48. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. 2000. Neutrophils: Molecules, functions and pathophysiological aspects. Laboratory Investigation 80:617-653.
49. Xu Q. 2002. Role of heat shock proteins in atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology 22:1547-1559.
50. Zhong L, Peng X, Hidalgo GE, Doherty DE, Stromberg AJ, Hirschowitz EA. 2003. Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detection and Prevention 27:285-290.